Nos publications

Mise à jour novembre 2023

Title Authors Year Trier par ordre décroissant Journal Link to Article Intended Audience Purpose
FcgRIIa proteolysis as a diagnostic biomarker for heparin-induced thrombocytopenia Nazi I, Arnold DM, Smith JW, Horsewood P, Moore JC, Warkentin TE, Crowther MA, Kelton JG 2013 J Thromb Haemost Researchers Basic research
Co-stimulation with LPS or Poly I:C markedly enhances the anti-platelet immune response and severity of fetal and neonatal alloimmune thrombocytopenia Li C, Chen P, Vadasz B, Ma L, Zhou H, Lang S, Freedman J, Ni H 2013 Thromb Haemost Researchers Basic research
Quality of red blood cells washed using the ACP 215 cell processor: assessment of optimal pre- and postwash storage times and conditions Hansen A, Yi QL, Acker JP 2013 Transfusion Researchers New or improved product or process
Adjudication of bleeding outcomes in an international thromboprophylaxis trial in critical illness Arnold DM, Lauzier F, Rabbat C, Zytaruk N, Barlow Cash B, Clarke F, Heels-Ansdell D, Guyatt G, Walter SD, Davies A, Cook DJ, PROTECT Investigators on behalf of the Canadian Critical Care Trials Group and the Australian and New Zealand Intensive Care Clinical Trials Group 2013 Thromb Res Researchers Clinical research
Challenges in the management of the blood supply Williamson LM, Devine DV 2013 Lancet Blood operators Other
Fusion of the C-terminal triskaidecapeptide of hirudin variant 3 to alpha1-proteinase inhibitor M358R increases the serpin-mediated rate of thrombin inhibition Roddick LA, Bhakta V, Sheffield W 2013 BMC Biochem Researchers Basic research
Legal Aspects of the Blood System in Canada Reis NM 2013 Public Health Law and Policy in Canada Other Other
A case of vertical transmission of Chagas Disease contracted via blood transfusion in Canada Fearon MA, Scalia V, Huang M, Dines I, Ndao M 2013 Can J Infect Dis Med Microbiol Health care providers Clinical research
Positioning new treatments in the management of immune thrombocytopenia Arnold DM 2013 Pediatr Blood Cancer Researchers Clinical research
Amelioration of Murine Passive Immune Thrombocytopenia by IVIg and a Therapeutic Monoclonal CD44 Antibody Does Not Require the Myd88 Signaling Pathway Crow AR, Yu H, Han D, Lazarus AH 2013 PLoS One Researchers Basic research
Donor hemovigilance Goldman M 2013 Blood Transfus Health care providers Other
Expert approaches to common bleeding and thrombotic problems, part II Hayward CP, Webert KE 2013 Semin Thromb Hemost Health care providers Other
Research with Blood Donated to Blood Banking Organizations Reis NM 2013 Health Law Review Other Other
Utility of cross-matched platelet transfusions in patients with hypoproliferative thrombocytopenia: a systematic review Vassallo RR, Fung M, Rebulla P, Duquesnoy R, Saw CL, Slichter SJ, Tanael S, Shehata N, International Collaboration for Guideline Development Implementation Evaluation for Transfusion Therapies Collaborators 2013 Transfusion Researchers Clinical research
A platelet cover-up Arnold DM 2013 Blood Researchers Other
Legal Foundations of Public Health Law Reis NM 2013 Public Health Law and Policy in Canada Other Other
Phospholipidomics reveals differences in glycerophosphoserine profiles of hypothermically stored red blood cells and microvesicles Bicalho B, Holovati JL, Acker JP 2013 Biochim Biophys Acta Researchers Basic research
The complete N-terminal extension of heparin cofactor II is required for maximal effectiveness as a thrombin exosite 1 ligand Boyle AJ, Roddick LA, Bhakta V, Lambourne MD, Junop MS, Liaw PC, Weitz JI, Sheffield WP 2013 BMC Biochem Researchers Basic research
Alloimmunization of patients by blood units harboring distinct DEL variants St-Louis M, Lebrun A, Goldman M, Lavoie M 2013 Immunohematology Health care providers Clinical research
Fc-independent phagocytosis: Implications for IVIG and other therapies in immune-mediated thrombocytopenia Li J, van der Wal DE, Zhu L, Vadasz B, Simpson EK, Li C, Webster ML, Zhu G, Lang S, Chen P, Zeng Q, Ni H 2013 Cardiovasc Hematol Disord Drug Targets Researchers Other
Identifying D-positive donors using a second automated testing platform Goldman M, Resz I, Cote J, Ochoa G, Angus N 2013 Immunohematology Blood operators New or improved product or process
Riboflavin and ultraviolet light treatment of platelets triggers p38MAPK signaling: inhibition significantly improves in vitro platelet quality after pathogen reduction treatment Schubert P, Coupland D, Culibrk B, Goodrich RP, Devine DV 2013 Transfusion Researchers Basic research
CD4+ T-cells are unable to express the HIV natural resistance factor globotriosylceramide Kim M, Binnington B, Sakac D, Lingwood CA, Branch DR 2013 AIDS Researchers Basic research
Developing highly active small molecule ice recrystallization inhibitors based upon C-linked antifreeze glycoprotein analogues Trant JF, Briggs RA, Capicciotti C, Ben RN 2013 RSC Adv Researchers Basic research
ResearchUnit: Should patients receive HLA-selected platelets? Shehata N 2013 Blood.ca website Other Other
Utilization of frozen plasma in Ontario: a province wide audit reveals a high rate of inappropriate transfusions Tinmouth A, Thompson T, Arnold DM, Callum JL, Gagliardi K, Lauzon D, Owens W, Pinkerton P 2013 Transfusion Health care providers Benchmarking and standard setting
Different doses of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (Protocol) Estcourt LJ, Stanworth S, Doree C, Trivella M, Hopewell S, Murphy MF, Tinmouth A 2014 Cochrane Database Syst Rev Researchers Clinical research
Vitamin D and kidney transplant outcomes: a protocol for a systematic review and meta-analysis Hesketh CC, Knoll GA, Molnar AO, Tsampalieros A, Zimmerman DL 2014 Syst Rev Researchers Clinical research
A thermoreversible poly(choline phosphate) based universal biomembrane adhesive Yu X, Yang X, Horte S, Kizhakkedathu JN, Brooks DE 2014 Macromol Biosci Researchers Basic research
Does intravenous contrast-enhanced computed tomography cause acute kidney injury? Protocol of a systematic review of the evidence Kayibanda JF, Hiremath S, Knoll GA, Fergusson D, Chow BJ, Shabana W, Akbari A 2014 Syst Rev Researchers Clinical research
Evaluation of a universal point-of-issue assay for bacterial detection in buffy coat platelet components Ramirez-Arcos S, Kou Y, Perkins H 2014 Vox Sang Blood operators New or improved product or process
Feasibility and transport of packed red blood cells into Special Forces operational conditions Boscarino C, Tien H, Acker J, Callum J, Hansen AL, Engels P, Glassberg E, Nathens A, Beckett A 2014 J Trauma Acute Care Surg Other New or improved product or process
Reference intervals of complete blood count constituents are highly correlated to waist circumference: Should obese patients have their own “normal values?” Vuong J, Qiu Y, La M, Clarke G, Swinkels DW, Cembrowski G 2014 Am J Hematol Health care providers Clinical research
ResearchUnit: A Sweet Solution for Infant Transfusions? Acker JP 2014 Blood.ca website Other Other
Risks, benefits and the role of stakeholders in pathogen reduction technology Newbold KB, Heddle NM, Lane SJ, Arnold E, Eyles J, Webert K 2014 Health Risk Soc Other Other
The transcription factor Miz-1 is required for embryonic and stress-induced erythropoiesis but dispensable for adult erythropoiesis Kosan C, Rashkovan M, Ross J, Schaffer AM, Saba I, Lemsaddek W, Trudel M, Moroy T 2014 Am J Blood Res Researchers Basic research
A quality monitoring program for red blood cell components: in vitro quality indicators before and after implementation of semiautomated processing Acker JP, Hansen AL, Kurach JD, Turner TR, Croteau I, Jenkins C 2014 Transfusion Blood operators Benchmarking and standard setting
Prophylactic platelet transfusions: should they be a treatment of the past? Zeller MP, Al-Habsi KS, Heddle NM 2014 Curr Opin Hematol Health care providers Clinical research
Successful treatment with oseltamivir phosphate in a patient with chronic immune thrombocytopenia positive for anti-GPIb/IX autoantibody Shao L, Wu Y, Zhou H, Qin P, Ni H, Peng J, Hou M 2014 Platelets Health care providers Clinical research
Alpha-1 Acid Glycoprotein Reduces Hepatic Leukocyte Recruitment in Murine Models of Either Early Endotoxemia or Early Sepsis McCurdy TR, Patrick AL, Eltringham-Smith LJ, Bhakta V, Sheffield WP, Fox-Robichaud AE 2014 Microcirculation Researchers Basic research
Design, implementation, and evaluation of a knowledge translation intervention to increase organ donation after cardiocirculatory death in Canada: a study protocol Squires JE, Grimshaw JM, Taljaard M, Linklater S, Chasse M, Shemie SD, Knoll GA 2014 Implement Sci Researchers Other
Migration, proliferation and differentiation of cord blood mesenchymal stromal cells treated with histone deacetylase inhibitor valproic acid Marquez-Curtis LA, Qiu Y, Xu A, Janowska-Wieczorek A 2014 Stem Cells Int Researchers Basic research
ResearchUnit: Pathogen Inactivation for Safer Blood Transfusion: What are the Limitations? Schubert P 2014 Blood.ca website Other Other
An epidemiologic cohort study reviewing the practice of blood product transfusions among a population of pediatric oncology patients Lieberman L, Liu Y, Portwine C, Barty RL, Heddle NM 2014 Transfusion Health care providers Clinical research
Enhanced Pathogenicity of biofilm-negative Staphylococcus epidermidis isolated from platelet preparations Hodgson SD, Greco-Stewart V, Jimenez CS, Sifri CD, Brassinga AKC, Ramirez-Arcos S 2014 Transfusion Blood operators Basic research
Stability of relevant plasma protein activities in cryosupernatant plasma units during refrigerated storage for up to 5 days postthaw Bhakta V, Jenkins C, Ramirez-Arcos S, Sheffield WP 2014 Transfusion Blood operators New or improved product or process
Autologous stem cell transplantation for stiff person syndrome: two cases from the Ottawa blood and marrow transplant program Sanders S, Bredeson C, Pringle CE, Martin L, Allan D, Bence-Bruckler I, Hamelin L, Hopkins HS, Sabloff M, Sheppard D, Tay J, Huebsch L, Atkins HL 2014 JAMA Neurol Health care providers Clinical research
Levofloxacin for BK virus prophylaxis following kidney transplantation: a randomized clinical trial Knoll GA, Humar A, Fergusson D, Johnston O, House AA, Kim SJ, Ramsay T, Chasse M, Pang X, Zaltzman J, Cockfield S, Cantarovich M, Karpinski M, Lebel L, Gill JS 2014 JAMA Health care providers Clinical research
Osmotic parameters of red blood cells from umbilical cord blood Zhurova M, McGann LE, Acker JP 2014 Cryobiology Researchers Basic research
Physician registration for deceased organ donation Li AH, Dixon S, Prakash V, Kim SJ, Knoll GA, Lam NN, Garg AX 2014 JAMA Health care providers Other